Navigation Links
Vermillion to Host Teleconference and Webcast to Discuss Third Quarter 2007 Financial Results on November 12 at 4:30 pm Eastern Time
Date:11/9/2007

FREMONT, Calif., Nov. 9 /PRNewswire-FirstCall/ -- Vermillion, Inc. (Nasdaq: VRML), will announce third quarter 2007 financial results and business progress after market close on Monday, November 12, 2007. The company will also host a teleconference and webcast on Monday, November 12 at 4:30 p.m. Eastern Time.

To access the live conference call via phone, dial (877) 325-7371 from the United States and Canada or (+1 706) 634-0768 internationally. The conference ID is 21354673. Please dial-in approximately ten minutes prior to the start of the call. Additionally, you may access the live and subsequently archived webcast of the conference call from the Investor Relations section of the Company's website at http://www.vermillion.com. Please connect to the web site at least 15 minutes prior to the call to allow for any software download that may be necessary.

A telephone replay will be available beginning approximately two hours after the call through November 26 and may be accessed by dialing (800) 633-8284 from the United States and Canada or (+1 402) 977-9140 internationally. The replay passcode is 21354673. An archived replay of the webcast will be available until the next quarterly call.

About Vermillion, Inc.

Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has ongoing diagnostic programs in oncology/hematology, cardiology and women's health with an initial focus in ovarian cancer. Based in Fremont, California, more information about Verm
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Vermillion, Inc. Announces Receipt of Notice of Noncompliance From Nasdaq
2. Kensey Nash Corporation Announces its First Quarter 2008 Earnings Release Date and Teleconference
3. HMS Holdings Corp. Hosts Third Quarter 2007 Financial Teleconference and Presentation
4. Cepheid Schedules Teleconference and Webcast for Third Quarter 2007 Results
5. Onyx Pharmaceuticals Announces Third Quarter 2007 Financial Results Teleconference and Webcast
6. Webcast Alert: Kaiser Permanente Residency Program Open House
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Bear Stearns 20th Annual Healthcare Conference to Webcast Millennium Presentation
9. Nuvelo Announces Upcoming Conference Calls, Webcasts and Conference Participation
10. Webcast Alert: Heska Announces Third Quarter 2007 Earnings Conference Call Webcast
11. Exelixis Announces September 18 Webcast of Presentation at the Bank of America 2007 Investment Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...ad to a novel technique to combat cancer, study sa...ws) -- Belgian researchers have discovered that so...or food, and this might lead to new treatments tha... proliferate, all cells in the body need to produc... a process that requires oxygen. Compared with nor...
(Date:11/21/2008)...d To Vigorously Protect Investment And Restore Sha...ewswire-USNewswire/ -- Dr. Stephen Joffe, Craig Jo...heir Schedule 13D with the U.S. Securities and Exc...D disclosing ownership of 11.4% of LCA-Vision, Inc...ixed-site laser vision correction centers in 33 st...
(Date:11/21/2008)... Barr Pharmaceuticals, In...lders overwhelmingly approved the proposals submit... Teva Pharmaceuticals Industries Ltd. (Nasdaq: T...overwhelming support of the transaction by the Bar...rman and CEO. "We are pleased with the progress th...
(Date:11/21/2008)...ire/ -- In a statewide survey, 33 physicians crede...gery at Presbyterian Hospital of Dallas were honor...f " Super Doctors ." , , Each year, the pub...nal Media, Inc. to survey more than 38,000 medical...If you needed medical care, which doctor would you...
Breaking Medicine News(10 mins):Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4Health News:Annual List of 'Super Doctors' Features 33 Texas Institute for Surgery Physicians 2
...hemicals Ltd today said it will acquire the pharma... for 74.5 million dollars. // The company has sig... in CarboGen and Amcis--Solutia Inc's pharmaceutic...man said in a statement. The acquisition includes ...
...ems due to use of drugs in northeastern states, Mi...mar today suggested effective monitoring // and re...s a need to establish effective drug use monitorin...sister states in the northeastern region,Kumar sai...
...nce in the U.S. This shows an increase in 2.5 mil...t//. These individuals between the ages of 19 and...ens with no health insurance and Rite of Passage n... how the new policies will be helpful. They are no...
...l here, who have been abstaining from duty for a w.../ to introduce reservation in higher education ins...ke. The medicos, whose stir has disrupted medical...spital, stepped up their agitation with the hunger...
Other Medicine News:Health News:No Insurance For Young Adults In U.S. 2Health News:No Insurance For Young Adults In U.S. 3
(Date:11/21/2008)...rstCall/ -- Amgen,(Nasdaq: AMGN ) today announc...ucts for Human Use (CHMP) has issued a positive op...late(TM) (romiplostim) in the European Union,(EU)...mune (idiopathic),thrombocytopenia purpura (ITP) ...er treatments (e.g. corticosteroids, immunoglobuli...
(Date:11/20/2008)...w Jersey American Water has lifted the precaution...following municipalities in Middlesex, Somerset an... , , Dunellen , Edison , ...nfield , , , , Somerset County , ..., Green Brook , Hillsborough , ...
(Date:11/20/2008)...Call/ -- Bionovo, Inc.,(Nasdaq: BNVI ) announce...1B,clinical trial of their lead drug candidate fo...he Society for Integrative Oncology,s Fifth Intern...any,s oral presentation was selected,as a top sco...he Best of the,SIO Session on November 20, 2008. ...
(Date:11/20/2008)...-- The Scandinavian-based drug,development compan... on its,lead antimicrobial candidate LTX-109. Pre...owed that the novel lytic peptidomimetic has an ul...ter towards killing Staphylococcus,aureus and Str...ugs. In,addition to this it has proven effective ...
Breaking Medicine Technology:Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 2Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 3Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 4Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 5Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 6Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 7Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 8New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2NanoLogix Inc Presents at the National Hydrogen Association Conference 26 Provides Operations Management and Director Update 4275 1NanoLogix Inc Presents at the National Hydrogen Association Conference 26 Provides Operations Management and Director Update 4275 2NanoLogix Inc Presents at the National Hydrogen Association Conference 26 Provides Operations Management and Director Update 4275 3Spirit II Results Support Strength of Boston Scientifics Two Drug Eluting Stent Platforms 1636 1Spirit II Results Support Strength of Boston Scientifics Two Drug Eluting Stent Platforms 1636 2Spirit II Results Support Strength of Boston Scientifics Two Drug Eluting Stent Platforms 1636 3Spirit II Results Support Strength of Boston Scientifics Two Drug Eluting Stent Platforms 1636 4Study finds support for PCI in unprotected left main disease 15501 1Study finds support for PCI in unprotected left main disease 15501 2Study finds support for PCI in unprotected left main disease 15501 3Milestone Scientific Announces 2007 Year End Results 15497 1Milestone Scientific Announces 2007 Year End Results 15497 2Milestone Scientific Announces 2007 Year End Results 15497 3Milestone Scientific Announces 2007 Year End Results 15497 4Milestone Scientific Announces 2007 Year End Results 15497 5Milestone Scientific Announces 2007 Year End Results 15497 6Milestone Scientific Announces 2007 Year End Results 15497 7
Triad Plus Sterile Isopropyl Alcohol 70% USP Swabsticks are primarily used as a topical antiseptic prior to administering injections. They are gamma sterilized to meet AAMI/ANSI/ISO 11137 standar
...-I Prep Swabsticks are saturated with a 10% Po...vailable iodine. Povidone Iodine is virtually non-...is also non-staining to the skin or natural fabric...t; they are sturdy tools for removing small partic...
Aplicare's Saturated Swabsticks are packaged in easy open, single-use foil-laminated pouches. Each 4 inch Swabstick is saturated with precisely the correct amount of solution. Each package is termina
BD Persist Plus protective barrier provides a one-step antimicrobial barrier with minimum of 1% chlorhexidine with Up to 7-day antimicrobial effectiveness.
Medicine Products: